Gastrointestinal Tract: Bacterial Infections

Abstract

Almost every human will experience, at some stage in their life, an episode of diarrhoea due to a bacterial infection of the gastrointestinal tract. There are a variety of protective mechanisms in place, such as the high acid content of the stomach, to reduce the risk of such infections, but bacteria have evolved a variety of virulence factors, such as adhesion molecules and toxins, that enable active infections to take place. Enterotoxins, such as the cholera toxin, can cause a net secretion of water into the small bowel lumen, overwhelming the absorptive capacity of the large bowel. Cytotoxins can cause damage to the large bowel mucosa, leading to marked inflammation and causing bloody diarrhoea. Most cases of gastroenteritis can be treated with rehydration alone, but in some circumstances specific antimicrobial therapy is needed. This article highlights the pathogens implicated, the symptoms that usually result and the way such infections are managed.

Key Concepts:

  • Gastrointestinal infections due to bacteria are very common.

  • Bacteria that cause infection of the gastrointestinal tract have developed a variety of virulence factors, including adhesion molecules and toxin secretion.

  • Although most bacterial toxins are produced in the gut after infection, some are ingested preformed in food.

  • Watery diarrhoea is usually the result of enterotoxins acting in the small bowel, causing net secretion of water and electrolytes into the lumen.

  • Dysentery is bloody diarrhoea caused by bacteria that have caused inflammation in the large bowel mucosa.

  • Although Campylobacter species are the most common cause of sporadic bacterial food poisoning, more outbreaks are caused by Salmonella species.

  • Clostridium difficile has, in the past decade, become an important healthcare‐associated infection in hospitals in developed countries.

  • Enterotoxigenic E. coli (ETEC) is a very common cause of travellers’ diarrhoea.

  • Most cases of diarrhoea due to bacteria can be treated with rehydration therapy alone.

  • Although some bacterial infections of the gastrointestinal tract require specific antibiotic therapy, empiric therapy should only be given in certain circumstances to vulnerable patients to minimise overuse of antimicrobials.

Keywords: gastroenteritis; diarrhoea; fimbriae; enterotoxins; food poisoning; dysentery; cholera; enteric fever; Clostridium difficile; rehydration

References

Al‐Abri SS, Beeching NJ, Nye FC et al. (2005) Traveller's diarrhea. Lancet Infectious Diseases 5(6): 349–360.

Alam AN, Alam NH, Ahmed T and Sack DA (1990) Randomised double blind trial of single dose doxycycline for treating cholera in adults. British Medical Journal 300(6740): 1619–1621.

Allos BM, Moore MR, Griffin PM and Tauxe RV (2004) Surveillance for sporadic foodborne disease in the 21st century: the FoodNet perspective. Clinical Infectious Diseases 38(suppl. 3): S115–S120.

Avery ME and Snyder JD (1990) Oral therapy for acute diarrhea. The underused simple solution. New England Journal of Medicine 323(13): 891–894.

Beatty ME, Adcock PM, Smith SW et al. (2006) Epidemic diarrhea due to enterotoxigenic E. coli. Clinical Infectious Diseases 42(3): 329–334.

Bieber D, Ramer SW, Wu CY et al. (1998) Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic E. coli. Science 280(5372): 2114–2118.

CDC (2009) Multistate outbreak of Salmonella infections associated with peanut butter and peanut butter‐containing products – United States, 2008–2009. Morbidity and Mortality Weekly Report 58(4): 85–90.

DuPont HL and Hornick RB (1973) Adverse effect of lomotil therapy in shigellosis. Journal of American Medical Association 226(13): 1525–1528.

Gibreel A, Sjogren E, Kaijser B et al. (1998) Rapid emergence of high‐level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC. Antimicrobial Agents and Chemotherapy 42(12): 3276–3278.

Gorden J and Small PL (1993) Acid resistance in enteric bacteria. Infection and Immunity 61(1): 364–367.

Gould LH, Demma L, Jones TF et al. (2009) Hemolytic uremic syndrome and death in persons with E. coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000–2006. Clinical Infectious Diseases 49(1): 1480–1485.

Harris JC, Dupont HL and Hornick RB (1972) Fecal leukocytes in diarrheal illness. Annals of Internal Medicine 76(5): 697–703.

Holmgren J (1981) Actions of cholera toxin and the prevention and treatment of cholera. Nature 292(5822): 413–417.

Kelly CP and LaMont JT (2008) Clostridium difficile – more difficult than ever. New England Journal of Medicine 359(18): 1932–1940.

Kosek M, Bern C and Guerrant RL (2003) The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bulletin of the World Health Organization 81(3): 197–204.

Lan R, Lumb B, Ryan D and Reeves PR (2001) Molecular evolution of large virulence plasmid in Shigella clones and enteroinvasive E. coli. Infection and Immunity 69(10): 6303–6309.

Murphy GS, Bodhidatta L, Echeverria P et al. (1993) Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Annals of Internal Medicine 118(8): 582–586.

Ogawa M, Handa Y, Ashida H et al. (2008) The versatility of Shigella effectors. Nature Reviews. Microbiology 6(1): 11–16.

Parry CM, Ho VA, Phuong le T et al. (2007) Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin–azithromycin combination for treatment of multidrug‐resistant and nalidixic acid‐resistant typhoid fever. Antimicrobial Agents and Chemotherapy 51(3): 819–825.

Ramer SW, Schoolnik GK, Wu CY et al. (2002) The type IV pilus assembly complex: biogenic interactions among the bundle‐forming pilus proteins of enteropathogenic E. coli. Journal of Bacteriology 184(13): 3457–3465.

Rivas M, Sosa‐Estani S, Rangle J et al. (2008) Risk factors for sporadic Shiga toxin‐producing E. coli infections in children, Argentina. Emerging Infectious Diseases 14(5): 763–771.

Safdar N, Said A, Gagnon RE and Maki DG (2002) Risk of hemolytic uremic syndrome after antibiotic treatment of E. coli O157:H7 enteritis: a meta‐analysis. Journal American Medical Association 288(8): 996–1001.

Salam I, Katelaris P, Leigh‐Smith S and Farthing MJ (1994) Randomised trial of single‐dose ciprofloxacin for travellers’ diarrhoea. Lancet 344(8936): 1537–1539.

Simon GL and Gorbach SL (1984) Intestinal flora in health and disease. Gastroenterology 86(1): 174–193.

Tesh VL and O'Brien AD (1991) The pathogenic mechanisms of Shiga toxin and the Shiga‐like toxins. Molecular Microbiology 5(8): 1817–1822.

Warny M and Kelly CP (2003) Pathogenicity of Clostridium difficile toxins. In: Hecht GA (ed.) Microbial Pathogenesis and the Intestinal Epithelial Cell, pp. 503–524. Washington, DC: ASM Press.

WHO (2006) Oral Rehydration Salts: Production of the New ORS. Geneva. World Health Organisation.

Further Reading

Backer H (2001) Water disinfection for international and wilderness travelers. Clinical Infectious Diseases 34: 355.

Jones TF and Angulo FJ (2006) Food safety: eating in restaurants: a risk factor for foodborne disease? Clinical Infectious Diseases 43: 1324.

Mintz ED and Guerrant RL (2009) A lion in our village – the unconscionable tragedy of cholera. New England Journal of Medicine 360: 1060.

Robins‐Browne RM (2005) The relentless evolution of pathogenic E. coli. Clinical Infectious Diseases 41: 793.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Conlon, Christopher P(May 2010) Gastrointestinal Tract: Bacterial Infections. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0002219.pub2]